Nedocromil sodium is recommended for daily treatment of mild persistent asthma but its effect on cellular changes in asthmatic airways is poorly understood. We compared the antiinflammatory effects of nedocromil sodium and albuterol in 32 patients with asthma who received either nedocromil sodium 4 mg or albuterol 0.2 mg four times daily for 12 weeks according to a double-blind protocol. Patients underwent fiberoptic bronchoscopy, and lung function and bronchial responsiveness to histamine were measured. Numbers of inflammatory cells were studied by immunohistochemistry and image analysis. We were unable to identify any statistical differences between treatment groups for any of the variables measured. We conclude that our immunohistochemical study does not support the concept of nedocromil sodium as a potent/antiinflammatory drug.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nedocromil sodium
20
sodium albuterol
12
sodium
5
regular nedocromil
4
albuterol bronchial
4
bronchial inflammation
4
inflammation chronic
4
chronic asthma
4
nedocromil
4
asthma nedocromil
4

Similar Publications

Previous research suggests mitochondrial apoptosis alleviates rheumatoid arthritis (RA), but the role of mitochondrial apoptosis-related genes (MARGs) is unclear. Urgent exploration of RA-related mitochondrial apoptosis biomarkers is needed. Gene Expression Ontology (GEO)-derived RA datasets were used to identify differentially expressed genes (DEGs) compared to normal controls, intersected with MARGs to obtain differentially expressed mitochondrial apoptosis-related genes (DE-MARGs).

View Article and Find Full Text PDF
Article Synopsis
  • * The selected compounds underwent molecular docking to evaluate their binding to tryptase and were experimentally tested in rat basophilic leukemia cells to measure their efficacy in inhibiting tryptase and related activities.
  • * Results indicated that certain FDA-approved drugs, such as landiolol and cidofovir, effectively inhibited tryptase, showcasing machine learning's potential in drug repurposing and aiding the development of treatments for related diseases.
View Article and Find Full Text PDF

Background: Delirium is a prevalent neuropsychiatric medical phenomenon that causes serious emergency outcomes, including mortality and morbidity. It also increases the suffering and the economic burden for families and carers. Unfortunately, the pathophysiology of delirium is still unknown, which is a major obstacle to therapeutic development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!